Similar Papers

Paper Title
Journal
Date
Author
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial
Michael Szarek ...
Journal of the American College of Cardiology | VOL. 73
Michael Szarek, et. al.Michael Szarek ...
11 Nov 2018
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial.
Michael Szarek ...
European Heart Journal | VOL. 41
Michael Szarek, et. al.Michael Szarek ...
14 Oct 2020
Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
...
Circulation | VOL. 140
, et. al. ...
09 Jul 2019
Faculty Opinions recommendation of Effect of alirocumab on mortality after acute coronary syndromes.
Wilbert Aronow
-
Wilbert AronowWilbert Aronow
15 Aug 2019
View more papers

More From: Annals of Internal Medicine

Paper Title
Journal
Date
Author
Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022.
Yunfei Li ... Nicolas A Menzies
Annals of internal medicine | VOL. -
Yunfei Li, et. al.Yunfei Li ... Nicolas A Menzies
07 Feb 2025
In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y.
Eleni Korompoki ... James D Douketis
Annals of internal medicine | VOL. -
Eleni Korompoki, et. al.Eleni Korompoki ... James D Douketis
04 Feb 2025
Summary for Patients: Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings
-
Annals of Internal Medicine | VOL. -
--
04 Feb 2025
In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d
Mukul Sharma ... Abhilekh Srivastava
Annals of Internal Medicine | VOL. -
Mukul Sharma, et. al.Mukul Sharma ... Abhilekh Srivastava
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.